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Stenotrophomonas
maltophilia in
Salad 
To the Editor: Stenotrophomonas
maltophilia has emerged as an impor-
tant nosocomial pathogen, especially
in debilitated and immunocompro-
mised persons (1). However, compar-
atively little is known of the epidemi-
ology of this bacterium, and sources
and routes of transmission of S. mal-
tophilia are not well understood. The
bacterium is widely distributed in the
environment, including in plant rhi-
zospheres (2). Although environmen-
tal sources such as ice-making
machines have been implicated in
outbreaks of nosocomial S. maltophil-
ia  sepsis, the source of infection in
other outbreaks and in sporadic cases
often remains unidentified. Food as a
source of the bacterium has not been
investigated; given the association of
the bacterium with plants, we investi-
gated the prevalence of the bacterium
in salad vegetables. 
Salads were purchased from rep-
utable supermarkets and transported
immediately to the laboratory. Ten
grams of salad was homogenized in
90-mL sterile saline in a stomacher
for 1 to 2 min. Aliquots (200 µL) of
decimal dilutions of the homogenate
were plated onto vancomycin-imipen-
em-amphotericin B (VIA) agar (3)
and incubated for 24 to 48 h at 30°C.
Occasional imipenem-resistant envi-
ronmental bacteria, such as
Janthinobacterium lividum or van-
comycin-resistant Enterococcus faeci-
um, may grow on VIA, but the medi-
um contains a mannitol/bromothymol
blue indicator system, allowing these
bacteria, which produce acid from
mannitol, to be distinguished from S.
maltophilia. Putative S. maltophilia
colonies were further identified by the
API 20NE system (bioMérieux,
Marcy l’Etoile, France).
Susceptibilities of 9 confirmed iso-
lates to ceftazidime, chloramphenicol,
colistin sulfate, gentamicin, minocy-
cline, piperacillin/tazobactam, and
trimethoprim-sulfamethoxazole were
determined by using a disk diffusion
method.  Pseudomonas aeruginosa
(NCTC10662) was used as a control.
Because disk diffusion is not a reli-
able method for determining the sus-
ceptibility of S. maltophilia  to
quinolone antimicrobial agents (1),
the Etest was used. 
S. maltophilia was cultured from
14 (78%) of 18 salads. Numbers
ranged from 1.50 × 102 to 1.96 × 105
CFU/g (mean 1.75 × 105 CFU/g,
median 7.05 × 103 CFU/g). All isolates
were susceptible to ciprofloxacin, col-
istin sulfate, minocycline, and
trimethoprim-sulfamethoxazole. Eight
(89%) were resistant to chlorampheni-
col; 7 (78%) to piperacillin/tazobac-
tam; 5 (56%) to ceftazidime, and 2
(22%) to gentamicin.
All products examined were
labeled “washed and ready to eat,”
and, thus, consumers would be
unlikely to wash these products
before consumption. The growth
characteristics of S. maltophilia  in
products of this type, especially if
subject to temperature abuse, are
unknown, but in the domestic setting,
numbers of the bacterium may
increase before use.
All of the 9 isolates examined
exhibited resistance to >2 of the 8
agents tested, with 2 isolates resistant
to 4 compounds and thus had resist-
ance phenotypes similar to those of
strains associated with human infec-
tion. These findings are in agreement
with those of Berg (2), who reported
multiple resistances among isolates of
S. maltophilia associated with oilseed
rape. However, as with most strains of
clinical origin, all the isolates tested
here remained susceptible to
trimethoprim-sulfamethoxazole and
minocycline.
Although other investigators have
examined salad products for the
prevalence of pathogenic bacteria (4),
they did not attempt to isolate S. mal-
tophilia.  Another study may have
underestimated the prevalence of the
bacterium in these products since a
selective medium was not used (5).
We have shown in a clinical setting
that the use of a medium selective for
S. maltophilia improves the recovery
of this bacterium (6). Furthermore,
the optimal growth temperature of S.
maltophilia is 30°C, and incubation at
higher temperatures (7) may reduce
the likelihood of recovering the bac-
terium from food products. We rec-
ommend that future studies of S. mal-
tophilia in food products use a medi-
um such as VIA and that cultures be
incubated at 30oC.
Prepackaged, ready-to-eat salads,
such as those examined in this study,
are washed in chlorinated water
before sale. This measure is clearly
insufficient to remove S. maltophilia
from these items, possibly because the
bacterium may exist in biofilms in
some of the components of these
products. S. maltophilia is capable of
forming biofilms on a number of
materials (8). Alternatively, products
may become contaminated from envi-
ronmental sources in production
plants after washing.
The importance of S. maltophilia
in ready-to-eat salads, which are mar-
keted in a manner that assumes the
product does not need washing before
consumption, is unknown; neverthe-
less the presence of the bacterium in
these products serves to highlight rec-
ommendations that these items should
be avoided by severely immunocom-
promised persons, especially those
with neutropenia (9). Recently,
Apisarnthanarak et al. (10), in a
prospective study of hospitalized
oncology patients, identified intestin-
al colonization with S. maltophilia in
4 (9.5%) of 41 patients, which empha-
sizes that foodstuffs may be a poten-
tial source of this bacterium for some
patients. This is a preliminary study,
however, and further studies are need-
ed, in particular, molecular typing of
food and human-associated isolates,
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to investigate the hypothesis that
intestinal carriage of S. maltophilia
may follow consumption of contami-
nated foodstuffs.
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Avian Influenza
H5N1 and
Healthcare
Workers
To the Editor: Since January
2004, 35 human cases of avian
influenza A virus H5N1 have been
reported in Vietnam. Human-to-
human transmission of H5N1 is a
major concern, particularly because of
reported family clustering (1). Two
probable cases of human-to-human
transmission were recently reported
from Thailand (2), and evidence for
human-to-human transmission was
found in the 1997 Hong Kong out-
break (3). We evaluated healthcare
workers exposed to 2 patients
(patients 5 and 6 [1], referred to as
patients A and B, respectively, in this
article) with H5N1 infection, con-
firmed by polymerase chain reaction
(PCR), to determine the potential risk
for nosocomial human-to-human
transmission of H5N1.
Patient A was admitted to a gener-
al ward of a pediatric hospital in Ho
Chi Minh City on January 15, 2004,
on day 8 of illness; no infection con-
trol measures were taken at that time.
On January 18, 2004, she was trans-
ferred to the intensive care unit (ICU).
Eight hours after ICU admission, lim-
ited infection control measures were
implemented: the patient was trans-
ferred to a single room, and healthcare
workers were required to use dispos-
able surgical masks and gloves and
wear nondisposable gowns. However,
because resources were limited, each
healthcare worker wore only 1 glove.
On January 23, patient A was trans-
ferred to another hospital.
Patient B was admitted to the
infectious diseases ward of the pedi-
atric hospital on January 19, 2004, on
day 6 of illness; he was transferred to
the ICU after 4 hours and stayed there
until he died on January 23. Infection
control measures were implemented 2
days after ICU admission; these
measures were similar to those taken
for patient A except that no single
room was available.
From January 25 to 27, 2004, a
nasal swab specimen and baseline
serum sample were collected from
healthcare workers at the hospital;
each worker also completed a ques-
tionnaire. On February 9 and 10, fol-
low-up serum samples were collected.
Nasal swab samples were tested by
reverse transcription (RT)-PCR to
detect the H5 gene (1). Paired serum
samples were subjected to enzyme-
linked immunosorbent assay (ELISA)
(Virion/Serion, Würzburg, Germany)
to detect immunoglobulin G against
the nucleoprotein of influenza A;
samples were also subjected to an H5-
specific microneutralization assay (4).
Of 62 healthcare workers involved
in caring for patient A, patient B, or
both, 60 (97%) provided both samples
and questionnaires: 16 who cared for
patient Aon the general ward, 33 who
cared for patients A and B in the ICU,
and 11 who cared for patient B on the
infectious diseases ward or who were
consulted for diagnostic or clinical
procedures involving either patient.
Characteristics of the workers and
their exposures are shown in the
Table.
The median time between last
exposure and collection of the nasal
swab and the baseline serum samples
was 7 days (range 2–12 days). The
median time between last exposure
and collection of the follow-up serum
sample was 21 days (range 17–26
days). All 60 nasal swab samples were
negative by RT-PCR. Paired serum
samples were available from 46